Insights and Perspectives from the IFPMA and IFPW “Shaping a Sound Supply Chain Ecosystem” Panel Discussion at the 2016 Global Health Forum, 21 April 2016. Moderated by Sukana Virji, News Editor, Scrip Intelligence and featuring panelists: John Kallend, Sr. Vice President, Director of Manufacturer Relations and Services, Walgreens Boots Alliance and representing The International Federation...
Read moreProposals have been made recently to introduce a manufacturing exemption during the term of protection granted by incentive mechanisms, such as the Supplementary Protection Certificate (SPC) and Patent Term Restoration (PTR). These mechanisms are critically important to preserve incentives to develop new medicines and distribute them to patients by compensating for erosion of the patent term...
Read moreNEW YORK, 20 September 2016 (CSRWire) – In the side-lines of the United Nations General Assembly High-level Meeting on Antimicrobial Resistance (AMR) in New York, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) will convene a panel debate to discuss “The Role of Partnerships in Supporting Innovation to Combat Antimicrobial Resistance (AMR)” and report...
Read moreLeading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance Represents major milestone following the Industry Declaration signed in January 2016 at the World Economic Forum by more than 100 companies and trade associations NEW YORK, N.Y.,...
Read moreThis blog was originally posted on OECD Insights Antibiotics have made modern medicine possible. Before the discovery of penicillin in 1928 and the recognition of its therapeutic potential, there were few tools doctors could use when patients came to them with common or minor infections from simple paper cuts. Today, complex medical interventions are made...
Read moreGeneva, 14 September 2016 – The biopharmaceutical industry believes the UN High Level Panel on Access to Medicines (HLP) lent an unprecedented opportunity to address critical issues affecting the ability of millions of people in receiving the medicines and vaccines they need. Many of the HLP recommendations ignore the most common issues that hamper access...
Read moreAs regulatory stakeholders from around the world meet at the 17th International Conference of Drug Regulatory Authorities (ICDRA) in Cape Town, South Africa from 27 November to 2 December 2016 (http://www.icdra.co.za/), an open #preICDRA2016 conference, titled “Patients Are Waiting: How Regulators Collectively Make a Difference” will be convened from the 27-28 November 2016 at the...
Read moreResearch-based pharmaceutical industry contributes to key global health discussions at 69th World Health Assembly New resolutions adopted by the World Health Assembly included rules on relations the World Health Organization can have with the private sector, amongst others; structures for R&D funding and coordination; access to medicines and integrated health services; global sector strategies on...
Read more